You are here

Osteopathic Manipulative Treatment of Primary Dysmenorrhea and Related Factors: A Randomized Controlled Trial

Journal Name:

Publication Year:

Abstract (2. Language): 
Objectives: This study is aimed to evaluate if the osteopathic manipulative treatment (OMT) is effective in patients with primary dysmenorrhea (PD). Methods: Randomized single-blinded controlled trial with OMT group and lighttouch treatment (LTT) group. Recruited women were 18-40 years (mean age 27 years), with regular menstrual cycle, normal body mass index (BMI), and a medical diagnosis of PD. Intervention: Patients received five OMT or five LTT over a menstrual cycle. The primary outcomes were average menstrual pain assessed by the numeric rating scale (NRS), the duration of pain, and quality of life (QoL) assessed by the SF-12 Short Form Health Survey and Patient Global Impression Change (PGIC). The secondary outcomes were NSAIDs intake, hours of absence from school/work, and menstrual-related symptoms. Results: 31 subjects were enrolled, of which five were excluded and the remaining 26 were randomized. Patients in OMT group had significant improvement in every outcome, including the average menstrual pain that decreased from 5.35 ± 0.28 to 1.98 ± 0.24 (-63.0%; p<0.001). The mean SF-12 physical component score (PCS) improved from 31.35 ± 1.70 to 49.56 ± 1.92 (+58.1%, p<0.001), the mean SF-12 mental component score (MCS) improved from 38.36 ± 1.16 to 52.04 ± 0.94 (+35.7%; p<0.001). LTT group showed no improvements. Conclusion: OMT was effective in reducing menstrual pain and improving Quality of Life of dysmenorrheic women.
165
174

REFERENCES

References: 

[1] Dawood, M. Yusoff. “Primary dysmenorrhea: Advances in pathogenesis and management.” Obstetrics &
Gynecology Vol. 108, No. 2, 2006, pp. 428-41.
[2] Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: A
critical review.” Human Reproduction Update Vol. 21, No. 6, 2015, pp. 762-78.
Zecchillo, et al. Int J Med Res Health Sci 2017, 6(11): 165-174
173
[3] Zahradnik, Hans-Peter, Aida Hanjalic-Beck, and Klaus Groth. “Nonsteroidal anti-inflammatory drugs and
hormonal contraceptives for pain relief from dysmenorrhea: A review.” Contraception Vol. 81, No. 3, 2010, pp.
185-96.
[4] Durain, Dawn. “Primary dysmenorrhea: assessment and management update.” Journal of Midwifery & Women’s
Health Vol. 49, No. 6, 2004, pp. 520-28.
[5] Proctor, M. L., et al. “Spinal manipulation for primary and secondary dysmenorrhoea.” Cochrane Database Syst
Rev Vol. 4, 2001, p. CD002119.
[6] Nasir, Laeth, and Edward T. Bope. “Management of pelvic pain from dysmenorrhea or endometriosis.” The
Journal of the American Board of Family Practice Vol. 17. suppl 1, 2004, pp. S43-S47.
[7] Yu, Abigail. “Complementary and alternative treatments for primary dysmenorrhea in adolescents.” The Nurse
Practitioner Vol. 39, No. 11, 2014, pp. 1-12.
[8] Vincent, Katy, et al. “Dysmenorrhoea is associated with central changes in otherwise healthy women.” Pain Vol.
152, No. 9, 2011, pp. 1966-75.
[9] Yunus, Muhammad B. “Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and
overlapping conditions, and the related issue of disease versus illness.” Seminars in Arthritis and Rheumatism
Vol. 37. No. 6. WB Saunders, 2008.
[10] Proctor, Michelle, and Cynthia Farquhar. “Diagnosis and management of dysmenorrhoea.” BMJ: British Medical
Journal Vol. 332, No. 7550, 2006, p. 1134.
[11] Kannan, Priya, and Leica Sarah Claydon. “Some physiotherapy treatments may relieve menstrual pain in women
with primary dysmenorrhea: A systematic review.” Journal of Physiotherapy Vol. 60, No. 1, 2014, pp. 13-21.
[12] Molins-Cubero, Silvia, et al. “Changes in pain perception after pelvis manipulation in women with primary
dysmenorrhea: A randomized controlled trial.” Pain Medicine Vol. 15, No. 9, 2014, pp. 1455-63.
[13] Kokjohn, Katrina, et al. “The effect of spinal manipulation on pain and prostaglandin levels in women with
primary dysmenorrhea.” Journal of Manipulative and Physiological Therapeutics Vol. 15, No. 5, 1992, pp. 279-85.
[14] Fryer, Gary, and Alan J. Pearce. “The effect of lumbosacral manipulation on corticospinal and spinal reflex
excitability on asymptomatic participants.” Journal of manipulative and Physiological Therapeutics Vol. 35, No.
2, 2012, pp. 86-93.
[15] Schwerla, Florian, et al. “Osteopathic treatment in patients with primary dysmenorrhoea: A randomised controlled
trial.” International Journal of Osteopathic Medicine Vol. 17, No. 4, 2014, pp. 222-31.
[16] Dworkin, Robert H., et al. “Interpreting the clinical importance of treatment outcomes in chronic pain clinical
trials: IMMPACT recommendations.” The Journal of Pain Vol. 9, No. 2, 2008, pp. 105-21.
[17] Farrar, John T., et al. “Clinical importance of changes in chronic pain intensity measured on an 11-point numerical
pain rating scale.” Pain Vol. 94, No. 2, 2001, pp. 149-58.
[18] Hartman, Steve E. “Why do ineffective treatments seem helpful? A brief review.” Chiropractic & Osteopathy Vol.
17, No. 1, 2009, p. 10.
[19] Vickers, Andrew J., and Anton JM de Craen. “Why use placebos in clinical trials? A narrative review of the
methodological literature.” Journal of Clinical Epidemiology Vol. 53, No. 2, 2000, pp. 157-61.
[20] Allegri, Massimo, et al. “Mechanisms of low back pain: A guide for diagnosis and therapy.” F1000 Research Vol.
5, 2016.
[21] Fernández-De-Las-Peñas, CéSar, et al. “Immediate effects on pressure pain threshold following a single cervical
spine manipulation in healthy subjects.” Journal of Orthopaedic & Sports Physical Therapy Vol. 37, No. 6, 2007,
pp. 325-29.
[22] Brinkert, Willem, et al. “Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and
rectum.” Pain Vol. 132, 2007, pp. S46-S51.
[23] Skyba, D. A., et al. “Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not
opioid or GABA receptors in the spinal cord.” Pain Vol. 106, No. 1, 2003, pp. 159-68.
Zecchillo, et al. Int J Med Res Health Sci 2017, 6(11): 165-174
174
[24] Giamberardino, Maria Adele, et al. “Viscero-visceral hyperalgesia: characterization in different clinical
models.” Pain Vol. 151, No. 2, 2010, pp. 307-22.
[25] Akinci, A., et al. “Predictive factors and clinical biomarkers for treatment in patients with chronic pain caused
by osteoarthritis with a central sensitisation component.” International Journal of Clinical Practice Vol. 70, No.
1, 2016, pp. 31-44.
[26] Degenhardt, Brian F., et al. “Role of osteopathic manipulative treatment in altering pain biomarkers: A pilot
study.” The Journal of the American Osteopathic Association Vol. 107, No. 9, 2007, pp. 387-400.
[27] Simons, Laura E., Igor Elman, and David Borsook. “Psychological processing in chronic pain: a neural systems
approach.” Neuroscience & Biobehavioral Reviews Vol. 39, 2014, pp. 61-78.
[28] Rhudy, Jamie L., and Mary W. Meagher. “Fear and anxiety: divergent effects on human pain thresholds.” Pain Vol.
84, No. 1, 2000, pp. 65-75.
[29] Wunsch, Annabel, Pierre Philippot, and Léon Plaghki. “Affective associative learning modifies the sensory
perception of nociceptive stimuli without participant’s awareness.” Pain Vol. 102, No. 1, 2003, pp. 27-38.
[30] Tu, Cheng-Hao, et al. “Abnormal cerebral metabolism during menstrual pain in primary
dysmenorrhea.” Neuroimage Vol. 47, No. 1, 2009, pp. 28-35.

Thank you for copying data from http://www.arastirmax.com